Plasma calprotectin concentrations in women with endometrial carcinoma

Gynecologic Oncology

Volumn 114, Issue 3, 2009, Pages 491-495

  Ni Bhriain, Hannah ^a   Trovik, Jone ^b,c   Wik, Elisabeth ^c   Stefansson, Ingunn M ^c   Akslen, Lars A ^c   Salvesen, Helga B ^b,c   Staff, Anne Cathrine ^a,d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Biomarker; Calprotectin; Endometrial cancer; Inflammation; Ovarian cancer

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; MATRIX METALLOPROTEINASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SENESCENCE; THERAPY EFFECT; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 67749137100     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.008     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. Guo J., Yang E.C., Desouza L., Diehl G., Rodrigues M.J., Romaschin A.D., et al. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics 5 (2005) 1953-1966
3. Amant F., Moerman P., Neven P., Timmerman D., Van L.E., and Vergote I. Endometrial cancer. Lancet 366 (2005) 491-505
4. Odicino F., Pecorelli S., Zigliani L., and Creasman W.T. History of the FIGO cancer staging system. Int. J. Gynaecol. Obstet. 101 (2008) 205-210
5. Gadducci A., Cosio S., Carpi A., Nicolini A., and Genazzani A.R. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed. Pharmacother. 58 (2004) 24-38
6. Kaku T., Kamura T., Hirakawa T., Sakai K., Amada S., Kobayashi H., et al. Endometrial carcinoma associated with hyperplasia - immunohistochemical study of angiogenesis and p53 expression. Gynecol. Oncol. 72 (1999) 51-55
7. Salvesen H.B., Iversen O.E., and Akslen L.A. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. J. Clin. Oncol. 17 (1999) 1382-1390
8. Rose P.G. Endometrial carcinoma. N. Engl. J. Med. 335 (1996) 640-649
9. Linkov F., and Taioli E. Factors influencing endometrial cancer mortality: the Western Pennsylvania Registry. Future Oncol. 4 (2008) 857-865
10. Uharcek P. Prognostic factors in endometrial carcinoma. J. Obstet. Gynaecol. Res. 34 (2008) 776-783
11. Gebhardt C., Nemeth J., Angel P., and Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72 (2006) 1622-1631
12. Kristinsson J., Roseth A., Fagerhol M.K., Aadland E., Schjonsby H., Bormer O.P., et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis. Colon Rectum 41 (1998) 316-321
13. Odegaard E., Davidson B., Elgaaen B.V., Fagerhol M.K., Engh V., Onsrud M., et al. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary. Am. J. Obstet. Gynecol. 198 418 (2008) e1-e7
14. Arai K., Yamada T., and Nozawa R. Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med. Oncol. 17 (2000) 183-188
15. Arai K., Teratani T., Kuruto-Niwa R., Yamada T., and Nozawa R. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. Eur. J. Cancer 40 (2004) 1179-1187
16. Dale I., and Brandtzaeg P. Expression of the epithelial L1 antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology 14 (1989) 493-502
17. El-Rifai W., Moskaluk C.A., Abdrabbo M.K., Harper J., Yoshida C., Riggins G.J., et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62 (2002) 6823-6826
18. Murao S., Collart F.R., and Huberman E. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J. Biol. Chem. 264 (1989) 8356-8360
19. Yui S., Nakatani Y., and Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26 (2003) 753-760
20. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
21. Hermani A., Hess J., De S.B., Medunjanin S., Grobholz R., Trojan L., et al. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 11 (2005) 5146-5152
22. www.calpro.no